These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32122726)

  • 1. Tooth extractions in patients under antiresorptive therapy for osteoporosis: Primary closure of the extraction socket with a mucoperiosteal flap versus application of platelet-rich fibrin for the prevention of antiresorptive agent-related osteonecrosis of the jaw.
    Poxleitner P; Steybe D; Kroneberg P; Ermer MA; Yalcin-Ülker GM; Schmelzeisen R; Voss PJ
    J Craniomaxillofac Surg; 2020 Apr; 48(4):444-451. PubMed ID: 32122726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for managing medication-related osteonecrosis of the jaw.
    Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O; Peter JU
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012432. PubMed ID: 35866376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study.
    Asaka T; Ohga N; Yamazaki Y; Sato J; Satoh C; Kitagawa Y
    Clin Oral Investig; 2017 Sep; 21(7):2165-2172. PubMed ID: 27837344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental extractions for patients on oral antiplatelet: a within-person randomised controlled trial comparing haemostatic plugs, advanced-platelet-rich fibrin (A-PRF+) plugs, leukocyte- and platelet-rich fibrin (L-PRF) plugs and suturing alone.
    Giudice A; Esposito M; Bennardo F; Brancaccio Y; Buti J; Fortunato L
    Int J Oral Implantol (Berl); 2019; 12(1):77-87. PubMed ID: 31116189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of bisphosphonate-related osteonecrosis of the jaw using platelet-rich fibrin.
    Gönen ZB; Yılmaz Asan C
    Cranio; 2017 Sep; 35(5):332-336. PubMed ID: 27363584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Preventive Treatment Protocols for Patients under Antiresorptive Therapy Undergoing Tooth Extraction at a Swiss University Clinic.
    Pick E; Leuenberger N; Kuster I; Stutzmann NS; Stadlinger B; Valdec S
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
    Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
    J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary wound closure and perioperative antibiotic therapy for prevention of bisphosphonate-related osteonecrosis of the jaw after tooth extraction.
    Spanou A; Nelson K; Ermer MA; Steybe D; Poxleitner P; Voss PJ
    Quintessence Int; 2020; 51(3):220-228. PubMed ID: 32020132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of osteonecrosis of the jaw with the use of platelet-rich fibrin: a prospective study of 15 patients.
    Nørholt SE; Hartlev J
    Int J Oral Maxillofac Surg; 2016 Oct; 45(10):1256-60. PubMed ID: 27179556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Platelet Rich Fibrin (PRF)-Based Autologous Membranes for Tooth Extraction in Patients under Bisphosphonate Therapy: A Case Report.
    Pispero A; Bancora I; Khalil A; Scarnò D; Varoni EM
    Biomedicines; 2019 Nov; 7(4):. PubMed ID: 31717656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series.
    Fernando de Almeida Barros Mourão C; Calasans-Maia MD; Del Fabbro M; Le Drapper Vieira F; Coutinho de Mello Machado R; Capella R; Miron RJ; Gomes Alves G
    J Stomatol Oral Maxillofac Surg; 2020 Feb; 121(1):84-89. PubMed ID: 30794883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of a xenogeneic collagen matrix on extraction sockets: a new approach in ARONJ prevention (in german)].
    Kuster I; Valdec S; Rücker M; Bichsel D
    Swiss Dent J; 2020 Feb; 130(2):139-145. PubMed ID: 32031353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review.
    Lopez-Jornet P; Sanchez Perez A; Amaral Mendes R; Tobias A
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1067-72. PubMed ID: 27318752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - A retrospective study of 240 patients.
    Coropciuc R; Coopman R; Garip M; Gielen E; Politis C; Van den Wyngaert T; Beuselinck B
    Bone; 2023 May; 170():116722. PubMed ID: 36858337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of osteonecrosis of the jaw by mucoperiosteal coverage in a rat model.
    Abtahi J; Agholme F; Aspenberg P
    Int J Oral Maxillofac Surg; 2013 May; 42(5):632-6. PubMed ID: 23499148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report.
    Giudice A; Antonelli A; Muraca D; Fortunato L
    Indian J Dent Res; 2020; 31(5):813-818. PubMed ID: 33433526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid.
    Steller D; Herbst N; Pries R; Juhl D; Hakim SG
    Sci Rep; 2019 Jun; 9(1):8310. PubMed ID: 31165745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of leukocyte and platelet-rich fibrin in the prevention of medication-related osteonecrosis of the jaw, in patients requiring dental extractions: an observational study.
    Besi E; Pitros P
    Oral Maxillofac Surg; 2024 Jun; 28(2):785-793. PubMed ID: 38182917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ).
    Miranda M; Gianfreda F; Raffone C; Antonacci D; Pistilli V; Bollero P
    Biomed Res Int; 2021; 2021():4948139. PubMed ID: 34095295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.